Joe Springer

Long/short equity, value, special situations, growth
Joe Springer
Long/short equity, value, special situations, growth
Contributor since: 2012
Company: The Wall Street Exclusive
Astro-Med: Growth, Income, And Undervalued
Luby's Has Turnaround Upside And A Margin Of Safety
Martin Marietta Materials: Hoya Saxa!
5 Reasons To Take A Look At Telkonet
Tonix Is A Buy On Endpoint Circumstances
Unique Tonix Could Go Higher On BESTFIT Data
Tonix May Not Need Final Trial
10 Great Investments At Good Prices
Beat Most Fund Managers In One Step
5 Reasons Tonix Could Still Be A Multi-Bagger
6 Doubles In A Row And 2014's Top Pick
4 Reasons Tonix Could Be A Multi-Bagger
5 Reasons Hydrogenics Could Triple